Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed
Testosterone

Estradiol Levels in Men: Normal Range and Why It Matters

Updated 16 min read
Over-the-shoulder view of a doctor in a white coat holding a tablet that shows a rising trend line in a modern clinic, for an article on estradiol levels in men
Contents12 sections

A normal estradiol level for an adult man sits roughly between 8 and 40 pg/mL (about 29 to 147 pmol/L) when it’s measured with a sensitive mass spectrometry test. Mayo Clinic Laboratories lists 10 to 40 pg/mL for adult males, and Labcorp’s sensitive LC/MS test lists 8.0 to 35.0 pg/mL. The exact cutoffs depend on the lab and the test method.

Estradiol (E2) is the main form of estrogen, and men need it. It helps keep bones dense, supports libido and erections, and limits fat gain. Too little causes real problems. Too much can too, although the evidence on “too much” is thinner than most gym and forum advice suggests.

This guide covers what estradiol does in men, where it comes from, how to read a lab result, what high and low levels are linked to, and what happens to estradiol on testosterone replacement therapy (TRT).

This article is for educational purposes only and is not medical advice. It summarizes published research and guidelines. Don’t start, stop or change any medication without talking to your doctor. Read our full disclaimer for details.

Key Takeaways

  • Major labs put normal adult male estradiol at roughly 8 to 40 pg/mL (about 29 to 147 pmol/L) on sensitive LC-MS/MS tests. Mayo lists 10 to 40 pg/mL and Labcorp lists 8.0 to 35.0 pg/mL.
  • Standard immunoassays were built for women’s much higher levels and are less accurate at male levels. A sensitive (LC-MS/MS) test is the more reliable option for men.
  • A 2013 NEJM trial found estradiol deficiency mainly drove fat gain in men, while low testosterone drove muscle and strength loss. Both contributed to lower sexual function.
  • Breast tissue growth is the best-supported sign of high estradiol. Many other “high estrogen” symptoms have weak evidence behind them.
  • On TRT, estradiol usually rises with testosterone. Neither the Endocrine Society nor the AUA guideline recommends routine aromatase inhibitors, and pushing estradiol too low has been linked to bone loss in trials.

What Is a Normal Estradiol Level for a Man?

Here’s what three widely used lab tests list for adult men. The pmol/L figures are converted at about 3.67 pmol/L per pg/mL, which is the factor Mayo Clinic Laboratories gives for estradiol.

Lab and testMethodAdult male range (pg/mL)Approx. pmol/L
Mayo Clinic Laboratories, Estradiol, Serum (EEST)LC-MS/MS10 to 4037 to 147
Labcorp, Estradiol, Sensitive, LC/MS (140244)LC-MS/MS8.0 to 35.029 to 128
Labcorp, Estradiol (004515)Immunoassay (ECLIA)7.6 to 42.628 to 156

Sources: the Mayo Clinic Laboratories test catalog and the Labcorp test catalog entries for test 140244 [VERIFY: Labcorp’s 140244 page is offline; range taken from a hospital lab directory’s copy] and test 004515.

A few things are worth knowing before you compare your own result to these numbers.

Why labs give different ranges

Each lab builds its reference range from its own population and its own method. A reference range describes where most healthy men in that sample landed. It isn’t a target, and it doesn’t tell you what’s optimal for any one person.

Labcorp’s catalog also notes that estradiol results from different methods can’t be used interchangeably when tracking someone over time. If one test was an immunoassay and the next was LC-MS/MS, a change between them may be the method, not your body.

Estradiol doesn’t travel alone

Like testosterone, most estradiol in the blood is bound to proteins, including sex hormone binding globulin (SHBG). Standard tests report total estradiol. That’s one reason clinicians look at estradiol alongside total and free testosterone rather than in isolation. Our guide to the free testosterone range explains how SHBG changes the picture.

Why the Sensitive (LC-MS/MS) Test Matters for Men

Most standard estradiol tests are immunoassays. They were designed mainly for women of reproductive age, whose levels run far higher than men’s. Labcorp’s catalog entry for its standard immunoassay says estradiol levels in men are much lower than in women of reproductive age. For adult men, it states that a sensitive LC/MS assay is preferred over direct immunoassays because it’s more sensitive and less prone to interference from other steroids.

The problem is accuracy at the low end. A 2013 Endocrine Society position statement on estradiol testing concluded that the very low concentrations found outside reproduction are too low to be routinely measured accurately or precisely, and that methods and standardization needed to improve.

Two large studies of men show how much this matters:

  • The European Male Ageing Study (EMAS) comparison. Researchers measured estradiol in 3,174 European men aged 40 to 79 with both a common platform immunoassay and gas chromatography mass spectrometry. At lower estradiol levels the two methods barely agreed (correlation of 0.32). The immunoassay identified only 13.3% of the men that mass spectrometry classed as having low estradiol. The authors concluded the immunoassay may only be suitable for detecting high estradiol in men.
  • The MrOS and EMAS cohorts. A 2013 analysis of more than 6,000 men found that immunoassay estradiol tracked C-reactive protein, an inflammation marker, while mass spectrometry estradiol didn’t. The authors suggested something in the blood linked to inflammation was interfering with the immunoassay.

In practice, this means an immunoassay can make a man’s estradiol look higher than it is, and it is poor at catching genuinely low values. On a lab order, the sensitive version is usually labeled “estradiol, sensitive,” “ultrasensitive” or “LC-MS/MS.”

Where Estradiol Comes From in Men

Men make estradiol from testosterone. An enzyme called aromatase converts testosterone into estradiol, and this happens in many tissues, including fat, bone, brain and the testes themselves. Most of a man’s estradiol is made this way in tissues outside the testes, with a smaller share released directly by the testes.

Because fat tissue contains aromatase, body composition is one factor that affects how much conversion happens. So does the amount of testosterone available to convert. That second point is why estradiol tends to rise when testosterone rises, including on TRT.

The Endocrine Society’s 2018 testosterone guideline summarizes the division of labor this way: testosterone alone maintains lean mass and muscle strength, estradiol is needed to prevent increases in fat mass and hot flashes, and both are needed for sexual function and bone density.

What Estradiol Does in Men

The study that separated testosterone from estradiol

The clearest evidence comes from a trial by Joel Finkelstein and colleagues at Massachusetts General Hospital, published in the New England Journal of Medicine in 2013.

The researchers gave 400 healthy men aged 20 to 50 a drug (goserelin) that shut down their own testosterone and estradiol production. They then gave them different doses of testosterone gel, or a placebo gel, for 16 weeks. Half the men also took anastrozole, an aromatase inhibitor, which blocked the conversion of that testosterone into estradiol.

That design let the team see which changes came from losing testosterone and which came from losing estradiol:

  • Lean mass, muscle size and strength fell mainly because of androgen (testosterone) deficiency.
  • Body fat increased mainly because of estrogen deficiency.
  • Sexual function declined with both, so testosterone and estradiol each contributed.

The study was short and used healthy young men under artificial hormone suppression, so it doesn’t map perfectly onto older men or men on TRT. But it’s the strongest controlled evidence that estradiol does specific jobs in the male body.

Bone

A 2016 follow-up from the same trial, published in the Journal of Clinical Investigation, looked at bone. When aromatization was blocked, spine bone density measured by CT fell substantially at every testosterone dose. The authors concluded that estrogens primarily regulate bone turnover in adult men. Estradiol above about 10 pg/mL and testosterone above about 200 ng/dL were generally enough to prevent increased bone breakdown and bone density loss.

Rare genetic cases point the same way. A 1994 NEJM case report described a 28-year-old man whose estrogen receptor didn’t work. He was 204 cm tall with growth plates that hadn’t closed and very low spine bone density, despite normal testosterone. Men born unable to make aromatase show a similar pattern of tall stature, delayed bone maturation and osteopenia or osteoporosis, according to a 2009 clinical review. These are case reports of extreme deficiency, not evidence about small shifts within the normal range.

Libido and erections

The Finkelstein trial found that both hormones mattered for sexual function, with sexual desire generally falling as testosterone doses were lowered. Population data are less clear-cut. In an EMAS analysis of 2,838 men aged 40 to 79, measured by mass spectrometry, total and free testosterone were linked to overall sexual function, but estradiol was not. Estradiol was the only hormone linked to sexual function-related distress, with higher levels tied to more distress. That’s an observational association, and it can’t show cause.

Mood

Estradiol acts on the brain, and the Endocrine Society statement lists the brain among the many tissues it affects. Good human data on estradiol and mood in men are limited, though, and mostly observational. Claims that a specific estradiol number causes anxiety or low mood go beyond what the research shows.

Lipids

The evidence here is thin. A 1995 case report of a man unable to make aromatase described raised total and LDL cholesterol, raised triglycerides and lower HDL. On the other hand, a small 12-week trial in older men found that lowering estradiol with an aromatase inhibitor didn’t significantly change fasting lipids. One case report and one short trial don’t settle the question.

Symptoms of High Estrogen in Men

When estradiol is genuinely high, the best-supported sign is breast tissue growth (gynecomastia), sometimes with tenderness. A 2014 review in Nature Reviews Endocrinology explains that estrogens stimulate breast tissue growth while androgens inhibit it, and that most gynecomastia comes from too little androgen action or too much estrogen action in the breast. The same review lists other causes that are worth ruling out, including hyperthyroidism, certain testicular tumors and medicines such as spironolactone.

Other symptoms often blamed on high estrogen in men include:

  • Water retention or puffiness
  • Low libido or erection problems
  • Mood swings or irritability
  • Fat gain

These get repeated a lot, but the evidence linking them to a specific high estradiol level is weak. In the EMAS data above, erectile function tracked free testosterone, while estradiol wasn’t linked to overall sexual function. Many of these symptoms also overlap with low testosterone, poor sleep, high body fat and stress. A symptom on this list isn’t proof that estradiol is the cause.

Symptoms of Low Estrogen in Men

Low estradiol has a clearer trail of evidence, mostly from trials that deliberately lowered it and from rare genetic conditions:

  • Bone loss, shown in the Finkelstein bone study and in older men given an aromatase inhibitor (covered below)
  • Increased body fat, from the 2013 NEJM trial
  • Lower sexual desire and function, from the same trial
  • Hot flashes, which the Endocrine Society guideline attributes to estradiol deficiency

Outside of rare conditions, very low estradiol in men usually goes with very low testosterone or with drugs that block aromatase.

Is there a “U-shaped” risk?

Some observational data suggest both ends of the range carry risk. In a 2009 JAMA study of 501 men with chronic heart failure, men in the lowest and highest estradiol groups had higher death rates over three years than men in the middle. This was a sick population, estradiol was measured by immunoassay, and the design can’t prove cause. It fits the broader picture that more estradiol isn’t always worse and less isn’t always better.

How strong is the evidence?

ClaimMain evidenceStrength
Estradiol protects bone in menRandomized trials, genetic case reportsStrong
Low estradiol increases body fatRandomized trial (Finkelstein 2013)Moderate to strong
Estradiol supports libidoRandomized trial, observational dataModerate
High estradiol causes gynecomastiaMechanism and clinical reviewsModerate to strong
High estradiol causes erectile problems, mood swings or water retentionMostly anecdotal and observationalWeak
Estradiol affects lipids in menCase report, one small trialWeak, mixed

Estradiol on TRT

When a man starts TRT, more testosterone is available for aromatase to convert, so estradiol usually rises too. The AUA’s 2018 testosterone deficiency guideline notes that it’s not uncommon for estradiol to increase as total testosterone increases on therapy, and that clinicians should be aware symptomatic gynecomastia may follow.

What the guidelines say about aromatase inhibitors

Aromatase inhibitors such as anastrozole and exemestane block the testosterone-to-estradiol conversion. Some TRT providers prescribe one alongside testosterone. The two main guidelines are cautious:

  • Endocrine Society (2018). The guideline doesn’t recommend aromatase inhibitors as part of TRT. Its standard monitoring plan covers symptoms, side effects, testosterone levels, hematocrit and prostate cancer risk. Estradiol isn’t on that routine list.
  • American Urological Association (2018). The guideline says estradiol should be measured before starting therapy in men with breast symptoms or gynecomastia, and that men with high baseline estradiol should be referred to an endocrinologist. Its follow-up lab table lists estradiol testing as optional for other men. Aromatase inhibitors appear as an option for men with testosterone deficiency who want to maintain fertility (a conditional recommendation based on lower-grade evidence), not as a routine add-on to TRT.

Anastrozole’s FDA approval is for breast cancer, not for use in men. For a deeper look at how it’s used and studied in men, see our guide to anastrozole for men, and our comparison of Aromasin vs Arimidex for how the two drugs differ.

The risk of “crashing” estradiol

Pushing estradiol too low is where the research raises the clearest flags:

  • Bone density. In a 1-year randomized trial of 69 men aged 60 and over with low or borderline testosterone, an aromatase inhibitor raised testosterone and lowered estradiol, and spine bone density fell compared with placebo. The authors concluded aromatase inhibition doesn’t improve skeletal health in these men. The Finkelstein bone study found similar spine losses when aromatization was blocked.
  • Libido and sexual function. The 2013 NEJM trial showed estradiol contributes to sexual function, so driving it very low can work against one of the reasons men start TRT.
  • Body fat. The same trial linked estrogen deficiency to fat gain.
  • Lipids. As covered above, the data are limited and mixed.

Men who report “crashed” estradiol on forums often describe joint aches, low libido, flat mood and poor erections. Those are anecdotal reports, but several of them line up with what the controlled trials found. Our article on the best way to control estradiol on TRT looks at this trade-off in more detail.

A single high reading on TRT

Guidelines and clinicians describe a fairly consistent approach when estradiol comes back high on TRT, especially when the man has no symptoms:

  • Re-testing is common. A single reading, particularly from a standard immunoassay, is often repeated, ideally with a sensitive LC-MS/MS test.
  • Testosterone level and timing come first. Because estradiol tracks testosterone, clinicians usually check how high testosterone is running and when the blood was drawn relative to the last dose. The Endocrine Society suggests aiming for testosterone in the mid-normal range.
  • Hematocrit is checked. It’s part of routine TRT monitoring. The Endocrine Society guideline says that if hematocrit rises above 54%, therapy should be stopped until it falls to a safe level, then restarted at a reduced dose.
  • Symptoms matter. The AUA guideline focuses on breast symptoms and gynecomastia rather than on a number alone.

This is a description of what guidelines and clinicians report, not a treatment plan. Any change to dose or medication is a decision for the prescribing doctor.

What to Ask Your Doctor

If you’re getting your estradiol checked, or you’re on TRT and your result came back outside the range, these questions can help the conversation:

  • Was my estradiol measured with a sensitive LC-MS/MS test or a standard immunoassay?
  • What reference range does this lab use, and how does my result compare with my earlier tests on the same method?
  • Where was my testosterone at the time, and when was the blood drawn relative to my last dose?
  • Do I have any symptoms, like breast tenderness or growth, that point to estradiol being too high?
  • Should this be re-tested before anything changes?
  • If an aromatase inhibitor is suggested, what’s the evidence for it in my situation, and how would my bone density and estradiol be monitored?

If you’re comparing online TRT providers, it’s also worth asking which labs are included and how often. Our breakdown of online TRT cost covers what’s typically bundled into the price. For more on the hormone itself, see our estradiol profile.

The Bottom Line

Normal estradiol for an adult man is roughly 8 to 40 pg/mL on a sensitive test, and men need it for bone, sexual function and healthy body composition, so both very high and very low levels can cause problems.

  • Mayo Clinic Laboratories lists 10 to 40 pg/mL and Labcorp’s sensitive test lists 8.0 to 35.0 pg/mL, about 29 to 147 pmol/L across the two.
  • Standard immunoassays are unreliable at male levels, and a sensitive LC-MS/MS test gives a more accurate result.
  • Breast tissue growth is the best-supported sign of high estradiol, while many other “high estrogen” symptoms have weak evidence.
  • Neither major guideline recommends routine aromatase inhibitors on TRT, and trials link very low estradiol to bone loss.

Frequently Asked Questions

On a sensitive LC-MS/MS test, Mayo Clinic Laboratories lists 10 to 40 pg/mL for adult men and Labcorp lists 8.0 to 35.0 pg/mL. That works out to roughly 29 to 147 pmol/L. Ranges vary by lab and method, so compare your result to the range printed on your own report.
The best-supported sign is breast tissue growth or tenderness (gynecomastia). Water retention, low libido, erection problems and mood changes are often blamed on high estrogen, but the evidence tying them to a specific estradiol level is weak. Many of those symptoms overlap with low testosterone and other causes.
A sensitive LC-MS/MS test is more accurate at the low levels found in men. Standard immunoassays were designed mainly for women’s higher levels, and a study of 3,174 European men found they performed poorly at lower male estradiol levels. Labcorp’s catalog says the sensitive LC/MS test is preferred for men.
Usually, yes. TRT gives the aromatase enzyme more testosterone to convert, so estradiol tends to rise along with testosterone. The AUA guideline notes this is common and advises watching for breast symptoms.
Yes, most often when an aromatase inhibitor is used. Trials have linked low estradiol in men to bone density loss, increased body fat and lower sexual function. The Endocrine Society and AUA guidelines don’t recommend aromatase inhibitors as a routine part of TRT.

Disclaimer

Please read carefully

The information on this site is for educational and informational purposes only, and is not medical advice. This article summarizes laboratory reference ranges, clinical guidelines and published research on estradiol in men. Reference ranges differ between laboratories and test methods, and only a qualified healthcare professional can interpret your results in context. Some of the evidence described comes from observational studies, small trials or case reports, which cannot prove cause and effect. Testosterone and aromatase inhibitors are prescription medicines and should only be used under the care of a qualified healthcare professional. Do not start, stop or change any medication based on this article. Muscle & Brawn does not encourage or endorse the use of any hormone or hormone-modifying drug without a medical diagnosis and supervision. Research findings and guideline recommendations reflect the sources cited at the time of writing and may change.

Not medical advice

Content here is not a substitute for professional medical advice.

Consult your doctor

Talk to your doctor before starting any supplement or new routine.

Use at your own risk

We are not responsible for adverse effects from acting on this.

Do your research

Make informed decisions about your own health.

No guarantees

Individual results vary. No claims about outcomes.

Important — Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or your local emergency number right away.

Written & researched by

Daniel Louwrens BSc PT

The Morning Dose · Free weekly

The research that matters, in five minutes a week.

Join 300,000+ monthly readers getting the sharpest peptide, TRT, and SARMs research and news broken down without the hype. One email. No filler.

No spam. Unsubscribe anytime. 5-minute read, every week.
Latest issue #2

The Morning Dose #2: The “Wolverine Peptide” Fact-Checked, The Rock’s Real Routine, and What TRT Really Costs

BPC-157: what the research actually shows
The Rock: his real routine and diet, by era
Online TRT cost: the full bill and what comes first
Read time · 1 min Read this issue →

Our Trusted Brands

Our growing community of brands that value quality and innovation.